These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 9034168

  • 1. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV.
    FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
    [Abstract] [Full Text] [Related]

  • 2. Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.
    Alpha-Bazin B, Lorphelin A, Nozerand N, Charier G, Marchetti C, Bérenguer F, Couprie J, Gilquin B, Zinn-Justin S, Quéméneur E.
    Protein Sci; 2005 Jul; 14(7):1827-39. PubMed ID: 15987907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
    Callebaut I, Mornon JP.
    FEBS Lett; 1997 Jan 02; 400(1):25-30. PubMed ID: 9000507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X, Moréra S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJ, Lindahl T, Freemont PS.
    EMBO J; 1998 Nov 02; 17(21):6404-11. PubMed ID: 9799248
    [Abstract] [Full Text] [Related]

  • 7. Cancer predisposing mutations in BRCT domains.
    di Masi A, Gullotta F, Cappadonna V, Leboffe L, Ascenzi P.
    IUBMB Life; 2011 Jul 02; 63(7):503-12. PubMed ID: 21698754
    [Abstract] [Full Text] [Related]

  • 8. The BRCA1 C-terminal domain: structure and function.
    Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS.
    Mutat Res; 2000 Aug 30; 460(3-4):319-32. PubMed ID: 10946236
    [Abstract] [Full Text] [Related]

  • 9. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
    Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H, Rubin J, Miki T.
    J Cell Biochem; 2003 Nov 01; 90(4):819-36. PubMed ID: 14587037
    [Abstract] [Full Text] [Related]

  • 10. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
    Yamane K, Katayama E, Sugasawa K, Tsuruo T.
    Oncogene; 2000 Apr 13; 19(16):1982-91. PubMed ID: 10803459
    [Abstract] [Full Text] [Related]

  • 11. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
    Yamane K, Katayama E, Tsuruo T.
    Oncogene; 2001 May 24; 20(23):2859-67. PubMed ID: 11420698
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS, Green R, Glover JN.
    Nat Struct Biol; 2001 Oct 24; 8(10):838-42. PubMed ID: 11573086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA, Lowery DM, Nguyen A, Yaffe MB.
    Science; 2003 Oct 24; 302(5645):636-9. PubMed ID: 14576432
    [Abstract] [Full Text] [Related]

  • 15. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ, Ball LJ, Schmieder P, Leitner D, Strauss H, Wahl M, Kühne R, Oschkinat H, Heinemann U.
    Biochemistry; 2004 Dec 28; 43(51):15983-95. PubMed ID: 15609993
    [Abstract] [Full Text] [Related]

  • 16. TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.
    Wright RH, Dornan ES, Donaldson MM, Morgan IM.
    Biochem J; 2006 Dec 15; 400(3):573-82. PubMed ID: 16984230
    [Abstract] [Full Text] [Related]

  • 17. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
    Yamane K, Katayama E, Tsuruo T.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):678-84. PubMed ID: 11118345
    [Abstract] [Full Text] [Related]

  • 18. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP.
    Genes Dev; 2002 Mar 01; 16(5):583-93. PubMed ID: 11877378
    [Abstract] [Full Text] [Related]

  • 19. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M, Yu X, Chen J, Songyang Z.
    J Biol Chem; 2003 Dec 26; 278(52):52914-8. PubMed ID: 14578343
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Venere M, Snyder A, Zgheib O, Halazonetis TD.
    Cancer Res; 2007 Jul 01; 67(13):6100-5. PubMed ID: 17616665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.